News

Researchers funded by the National Institutes of Health have used a rapid DNA sequencing technique to identify gene variants in roughly a third of cases of nonimmune Hydrops fetalis (NIHF), a serious condition in which a fetus develops fluid buildup inside the abdominal cavity, lungs, or other parts of the body. The findings suggest that the DNA sequencing technique, known as exome sequencing, could be used to provide information unavailable with current genetic testing methods.

Opioid use among women trying to conceive may be associated with a lower chance of pregnancy, suggests a National Institutes of Health study. Moreover, opioid use in early pregnancy may be associated with a greater chance of pregnancy loss.

Researchers to evaluate medical records of 21,000 pregnant women

Program will include lessons learned from caring for pregnant women with COVID-19.

To expand the reach of its crowdsourcing pregnancy research project, the National Institutes of Health (NIH) recently launched a Spanish version of PregSource®.

Women who breastfed their infants exclusively for 7 to 12 months may have a significantly lower risk of early menopause than their peers who breastfed their infants for less than a month, according to an analysis funded by the National Institutes of Health.

Read about NICHD’s notable research findings and activities from 2019.

NICHD’s new initiative—Pregnancy for Every Body—educates plus-size pregnant women about healthy pregnancy and the importance of working with a healthcare provider to develop a pregnancy plan.

Feeling stressed was linked to lower chances of ovulation, conception, and pregnancy among women who had earlier experienced a pregnancy loss, according to an analysis by researchers at the NICHD.

Pregnant women who are exposed to higher air pollution levels during their second pregnancy, compared to their first one, may be at greater risk of preterm birth, according to researchers at the National Institutes of Health.

Improved data reporting among the factors critical to reducing life-threatening complications of pregnancy and childbirth

Patient advocates, healthcare providers and researchers help map a future research agenda aimed at reducing maternal mortality and severe morbidity.

NICHD was established more than 50 years ago to help understand maternal health and improve pregnancy outcomes. These selected advances highlight NICHD’s contributions to advancing the health and well-being of pregnant women, mothers, and families everywhere.

Group seeks to enhance testing of therapeutics used by pregnant women and nursing mothers.

Each year in the United States, 700 women die from pregnancy or childbirth complications – one of the highest maternal death rates in the developed world. Listen to Milestones interview with Dr. Juanita Chinn from NICHD’s Population Dynamics Branch.

The anti-inflammatory properties of testosterone appear to protect male mouse embryos from certain types of DNA damage and inflammation that are fatal to female mouse embryos, according to a recent NICHD-supported study.

In 2018, researchers funded by NICHD made significant progress in advancing the health and well-being of infants, children, teenagers, and adults across the United States and around the world.

Among women planning to conceive after a pregnancy loss, those who had sufficient levels of vitamin D were more likely to become pregnant and have a live birth, compared to women with insufficient levels of the vitamin, according to an analysis by researchers at the National Institutes of Health.